Robert E. Reiter
Corporate Officer/Principal bij Jonsson Comprehensive Cancer Center
Profiel
Robert E.
Reiter is the founder of ImaginAb, Inc. which was founded in 2007.
He is currently the Director-Genitourinary Cancer Program at Jonsson Comprehensive Cancer Center and a Professor-Urology & Molecular Biology at David Geffen School of Medicine.
Dr. Reiter received his undergraduate degree from Yale University and his doctorate from Stanford University School of Medicine.
Actieve functies van Robert E. Reiter
Bedrijven | Functie | Begin |
---|---|---|
Jonsson Comprehensive Cancer Center | Corporate Officer/Principal | - |
David Geffen School of Medicine | Corporate Officer/Principal | - |
Eerdere bekende functies van Robert E. Reiter
Bedrijven | Functie | Einde |
---|---|---|
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Oprichter | - |
Opleiding van Robert E. Reiter
Yale University | Undergraduate Degree |
Stanford University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Health Technology |
Jonsson Comprehensive Cancer Center |